172 related articles for article (PubMed ID: 30702600)
41. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
[TBL] [Abstract][Full Text] [Related]
42. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
[TBL] [Abstract][Full Text] [Related]
43. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
[TBL] [Abstract][Full Text] [Related]
44. Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada S; Ichiyasu H; Ikeda T; Inaba M; Kashiwabara K; Sadamatsu T; Sato N; Akaike K; Okabayashi H; Saruwatari K; Tomita Y; Saeki S; Hirata N; Yoshinaga T; Fujii K
BMC Pulm Med; 2019 Apr; 19(1):72. PubMed ID: 30940113
[TBL] [Abstract][Full Text] [Related]
45. Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.
Salonen J; Jansa S; Vähänikkilä H; Kaarteenaho R
BMC Pulm Med; 2023 Jul; 23(1):236. PubMed ID: 37393286
[TBL] [Abstract][Full Text] [Related]
46. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
[TBL] [Abstract][Full Text] [Related]
47. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Hozumi H; Kono M; Hasegawa H; Kato S; Inoue Y; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respir Res; 2022 Mar; 23(1):57. PubMed ID: 35277175
[TBL] [Abstract][Full Text] [Related]
48. What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?
Miyajima M; Watanabe A; Sato T; Teramukai S; Ebina M; Kishi K; Sugiyama Y; Kondo H; Kobayashi S; Takahashi Y; Ito H; Yamamoto R; Sawada S; Fujimori H; Okabe K; Arikura J; Shintani Y; Nakamura H; Toyooka S; Hasumi T; Watanabe T; Hata Y; Iwata H; Aoki M; Funai K; Inoue S; Kawashima O; Iida T; Date H
Surg Today; 2018 Apr; 48(4):404-415. PubMed ID: 29124429
[TBL] [Abstract][Full Text] [Related]
49. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
Kimura T; Nojiri T; Hosoda H; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e85-91. PubMed ID: 26224340
[TBL] [Abstract][Full Text] [Related]
50. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
Enomoto N; Naoi H; Mochizuka Y; Isayama T; Tanaka Y; Fukada A; Aono Y; Katsumata M; Yasui H; Mori K; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
BMC Pulm Med; 2022 Oct; 22(1):387. PubMed ID: 36289542
[TBL] [Abstract][Full Text] [Related]
51. The balance between lung regulatory T cells and Th17 cells is a risk indicator for the acute exacerbation of interstitial lung disease after surgery: a case-control study.
Fukui M; Harada N; Takamochi K; Hayashi T; Matsunaga T; Hattori A; Kawagoe I; Suzuki K
BMC Pulm Med; 2023 Feb; 23(1):70. PubMed ID: 36814205
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis.
Wu T; Zhang Y; Cen Z; Ying Y; Sun C; Lv C; Ding Q
Ther Adv Respir Dis; 2022; 16():17534666221140974. PubMed ID: 36484348
[TBL] [Abstract][Full Text] [Related]
53. Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.
Adams CJ; Chohan K; Rozenberg D; Kavanagh J; Greyling G; Shapera S; Fisher JH
Lung; 2021 Aug; 199(4):379-387. PubMed ID: 34347146
[TBL] [Abstract][Full Text] [Related]
54. Pulse oximetric saturation to fraction of inspired oxygen (SpO
Koyauchi T; Yasui H; Enomoto N; Hasegawa H; Hozumi H; Suzuki Y; Karayama M; Furuhashi K; Fujisawa T; Nakamura Y; Inui N; Yokomura K; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620906327. PubMed ID: 32046604
[TBL] [Abstract][Full Text] [Related]
55. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
56. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.
Kenmotsu H; Naito T; Kimura M; Ono A; Shukuya T; Nakamura Y; Tsuya A; Kaira K; Murakami H; Takahashi T; Endo M; Yamamoto N
J Thorac Oncol; 2011 Jul; 6(7):1242-6. PubMed ID: 21623239
[TBL] [Abstract][Full Text] [Related]
57. Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy.
Sekine A; Matama G; Hagiwara E; Tabata E; Ikeda S; Oda T; Okuda R; Kitamura H; Baba T; Satoh H; Misumi T; Komatsu S; Iwasawa T; Ogura T
Thorac Cancer; 2022 Sep; 13(17):2443-2449. PubMed ID: 35840339
[TBL] [Abstract][Full Text] [Related]
58. Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.
Kakiuchi S; Hanibuchi M; Tezuka T; Saijo A; Otsuka K; Sakaguchi S; Toyoda Y; Goto H; Kawano H; Azuma M; Ogushi F; Nishioka Y
Respir Investig; 2017 Mar; 55(2):145-152. PubMed ID: 28274530
[TBL] [Abstract][Full Text] [Related]
59. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients.
Sato T; Kondo H; Watanabe A; Nakajima J; Niwa H; Horio H; Okami J; Okumura N; Sugio K; Teramukai S; Kishi K; Ebina M; Sugiyama Y; Kondo T; Date H
Gen Thorac Cardiovasc Surg; 2015 Mar; 63(3):164-72. PubMed ID: 25352311
[TBL] [Abstract][Full Text] [Related]
60. Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Québec.
Storme M; Semionov A; Assayag D; Lefson M; Kitty D; Dannenbaum D; Torrie J; Lejeune P; Robinson E; Ahmad Khan F
PLoS One; 2017; 12(9):e0184548. PubMed ID: 28886193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
